INTS — INTENSITY THERAPEUTICS INC
As of Q2 2026, 3 SEC-registered investment managers reported holding INTS (INTENSITY THERAPEUTICS INC) in their latest 13F filings, with a combined reported value of $93.51K across 22.81K shares. That is -13.7% by share count (-3.62K shares) versus the previous quarter, while reported value moved -39.8%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 2 trimmed, 1 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
INTS is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Vanguard Group history | Q4 2025 | 649.08K | $266.12K | 0.00% | Add |
| Millennium Management history | Q3 2023 | 24.82K | $101.27K | 0.00% | New |
| Geode Capital Management history | Q2 2026 | 22.79K | $93.43K | 0.00% | Reduce |
| Citadel Advisors history | Q1 2025 | 25.80K | $50.83K | 0.00% | Add |
| BlackRock Inc history | Q1 2025 | 21.84K | $43.01K | 0.00% | Reduce |
| Northern Trust Corp history | Q4 2025 | 75.54K | $30.99K | 0.00% | Add |
| Wells Fargo & Co history | Q1 2026 | 200 | $1.18K | 0.00% | New |
| Bank of America Corp history | Q4 2025 | 584 | $240 | 0.00% | Reduce |
| Morgan Stanley history | Q2 2026 | 20 | $82 | 0.00% | Hold |
| Citigroup Inc history | Q4 2025 | 88 | $36 | 0.00% | Reduce |
| Fidelity Management & Research (FMR) history | Q2 2025 | 100 | $31 | 0.00% | New |
| JPMorgan Chase & Co history | Q1 2025 | 15 | $30 | 0.00% | Reduce |
| UBS Group AG history | Q2 2026 | 1 | $4 | 0.00% | Reduce |
New Positions (Q2 2026)
No fund opened a new position this quarter.
Fully Exited (vs previous quarter)
- Wells Fargo & Co sold 200 sh · $1.18K
Fund Position History — shares by quarter (top 13 funds)
| Fund | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Geode Capital Management | 23.07K | 45.36K | 47.62K | 47.62K | 64.35K | 64.35K | 77.48K | 72.81K | 258.89K | 460.25K | 26.02K | 22.79K |
| Morgan Stanley | — | — | — | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 20 | 20 |
| UBS Group AG | — | 500 | 3.01K | 3.32K | 20.61K | 3.02K | 3.10K | 9.23K | 136.23K | 25.40K | 192 | 1 |
| Bank of America Corp | — | 6 | — | 219 | 49 | 50 | 63 | 388 | 620 | 584 | — | — |
| Citigroup Inc | — | — | — | — | — | — | — | — | 44.58K | 88 | — | — |
| Northern Trust Corp | — | — | — | — | — | — | 14.02K | 14.02K | 14.02K | 75.54K | — | — |
| Vanguard Group | — | 83.07K | 177.19K | 204.97K | 208.89K | 208.89K | 230.66K | 40.59K | 255.93K | 649.08K | — | — |
| Wells Fargo & Co | 2.48K | 2.48K | 2.48K | 3.45K | 3.45K | — | — | — | — | — | 200 | — |
| Citadel Advisors | — | — | — | — | — | 14.96K | 25.80K | — | — | — | — | — |
| BlackRock Inc | — | — | — | — | 22.11K | 22.25K | 21.84K | — | — | — | — | — |
| Fidelity Management & Research (FMR) | — | — | — | — | — | — | — | 100 | — | — | — | — |
| JPMorgan Chase & Co | 1 | 40 | 8.87K | 18 | 17 | 17 | 15 | — | — | — | — | — |
| Millennium Management | 24.82K | — | — | — | — | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details